Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,485 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Phase 2b, Randomised, Double-blind, Placebo-controlled, Parallel-arm, Multicenter Study Evaluating the Safety and Efficacy of Tesnatilimab in Patients with Moderately to Severely Active Crohn's Disease.
Allez M, Sands BE, Feagan BG, D'Haens G, De Hertogh G, Randall CW, Zou B, Johanns J, O'Brien C, Curran M, Rebuck R, Wang ML, Sabins N, Baker T, Kobayashi T. Allez M, et al. Among authors: baker t. J Crohns Colitis. 2023 Aug 21;17(8):1235-1251. doi: 10.1093/ecco-jcc/jjad047. J Crohns Colitis. 2023. PMID: 36939629 Clinical Trial.
Dynamics of karyotype evolution.
Kuzmin E, Baker TM, Van Loo P, Glass L. Kuzmin E, et al. Among authors: baker tm. Chaos. 2024 May 1;34(5):051502. doi: 10.1063/5.0206011. Chaos. 2024. PMID: 38717409
Care of the critically ill begins in the emergency medicine setting.
Critical Care in Emergency Medicine Interest Group. Critical Care in Emergency Medicine Interest Group. Eur J Emerg Med. 2024 Jun 1;31(3):165-168. doi: 10.1097/MEJ.0000000000001134. Epub 2024 Apr 17. Eur J Emerg Med. 2024. PMID: 38635471 Free PMC article. No abstract available.
Type I interferon blockade with anifrolumab in patients with systemic lupus erythematosus modulates key immunopathological pathways in a gene expression and proteomic analysis of two phase 3 trials.
Baker T, Sharifian H, Newcombe PJ, Gavin PG, Lazarus MN, Ramaswamy M, White WI, Ferrari N, Muthas D, Tummala R, Morand EF, Furie R, Vital EM, Chamberlain C, Platt A, Al-Mossawi H, Brohawn PZ, Csomor E. Baker T, et al. Ann Rheum Dis. 2024 May 3:ard-2023-225445. doi: 10.1136/ard-2023-225445. Online ahead of print. Ann Rheum Dis. 2024. PMID: 38569851 Free article.
2,485 results